Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dianne J Beveridge

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|October 6, 2011
The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cellsMichael R Epis, Andrew Barker, Keith M Giles, et al.
International Journal of Molecular Sciences|September 14, 2024
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic OpportunitiesKhadijeh Mahboobnia, Dianne J Beveridge, George C Yeoh, et al.
The Journal of Biological Chemistry|August 23, 2003
HADHB, HuR, and CP1 bind to the distal 3'-untranslated region of human renin mRNA and differentially modulate renin expressionDavid J Adams, Dianne J Beveridge, Louise van der Weyden, et al.
Scientific Reports|September 10, 2021
The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancerDianne J Beveridge, Kirsty L Richardson, Michael R Epis, et al.
The Journal of Biological Chemistry|November 15, 2002
The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding proteinKeith M Giles, John M Daly, Dianne J Beveridge, et al.
Scientific Reports|October 21, 2025
PACT is requisite for prostate cancer cell proliferationDianne J Beveridge, Andrew J Woo, Kirsty L Richardson, et al.
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
International Journal of Molecular Sciences|May 14, 2025
MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1Khadijeh Mahboobnia, Tasnuva D Kabir, Rui Hou, et al.
Cancers|October 16, 2025
Systematic Review and Meta-Analysis of microRNA-7-5p Expression and Biological Significance in Head and Neck Squamous Cell CarcinomaRikki A M Brown, Michael Phillips, Andrew J Woo, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2017
Evaluation of MicroRNA Delivery In VivoRikki A M Brown, Kirsty L Richardson, Felicity C Kalinowski, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|October 6, 2011
The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cellsMichael R Epis, Andrew Barker, Keith M Giles, et al.
International Journal of Molecular Sciences|September 14, 2024
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic OpportunitiesKhadijeh Mahboobnia, Dianne J Beveridge, George C Yeoh, et al.
The Journal of Biological Chemistry|August 23, 2003
HADHB, HuR, and CP1 bind to the distal 3'-untranslated region of human renin mRNA and differentially modulate renin expressionDavid J Adams, Dianne J Beveridge, Louise van der Weyden, et al.
Scientific Reports|September 10, 2021
The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancerDianne J Beveridge, Kirsty L Richardson, Michael R Epis, et al.
The Journal of Biological Chemistry|November 15, 2002
The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding proteinKeith M Giles, John M Daly, Dianne J Beveridge, et al.
Scientific Reports|October 21, 2025
PACT is requisite for prostate cancer cell proliferationDianne J Beveridge, Andrew J Woo, Kirsty L Richardson, et al.
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
International Journal of Molecular Sciences|May 14, 2025
MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1Khadijeh Mahboobnia, Tasnuva D Kabir, Rui Hou, et al.
Cancers|October 16, 2025
Systematic Review and Meta-Analysis of microRNA-7-5p Expression and Biological Significance in Head and Neck Squamous Cell CarcinomaRikki A M Brown, Michael Phillips, Andrew J Woo, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2017
Evaluation of MicroRNA Delivery In VivoRikki A M Brown, Kirsty L Richardson, Felicity C Kalinowski, et al.
Pageof 2